IKS - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.8
| Stock Code | IKS | Market Cap | 27,045 Cr. | Current Price | 1,571 ₹ | High / Low | 1,929 ₹ |
| Stock P/E | 62.3 | Book Value | 86.2 ₹ | Dividend Yield | 0.00 % | ROCE | 35.0 % |
| ROE | 32.3 % | Face Value | 1.00 ₹ | DMA 50 | 1,644 ₹ | DMA 200 | 1,639 ₹ |
| Chg in FII Hold | 0.54 % | Chg in DII Hold | 1.17 % | PAT Qtr | 138 Cr. | PAT Prev Qtr | 113 Cr. |
| RSI | 37.4 | MACD | -25.4 | Volume | 73,023 | Avg Vol 1Wk | 3,58,848 |
| Low price | 1,226 ₹ | High price | 1,929 ₹ | PEG Ratio | 3.59 | Debt to equity | 0.07 |
| 52w Index | 49.0 % | Qtr Profit Var | 50.2 % | EPS | 25.3 ₹ | Industry PE | 25.7 |
💹 Core Financials: IKS demonstrates strong profitability with ROE at 32.3% and ROCE at 35.0%, reflecting efficient capital utilization. Quarterly PAT rose from ₹113 Cr. to ₹138 Cr., showing a 50.2% improvement. Debt-to-equity ratio of 0.07 indicates low leverage, ensuring financial stability. Dividend yield is 0%, suggesting reinvestment of earnings rather than shareholder payouts.
📊 Valuation Indicators: Current P/E of 62.3 is significantly higher than the industry average of 25.7, indicating overvaluation. P/B ratio (~18.2) is steep relative to book value. PEG ratio of 3.59 suggests limited growth-adjusted value. Intrinsic value analysis points to the stock being expensive at current levels, with little margin of safety.
🏢 Business Model & Competitive Advantage: IKS operates with a strong industrial and technology-driven model, leveraging innovation and efficiency. Its competitive advantage lies in high return ratios, strong institutional investor interest, and consistent earnings growth. However, elevated valuations and relatively low liquidity pose challenges.
📈 Entry Zone: Technical indicators (DMA 50: ₹1,644, DMA 200: ₹1,639, RSI: 37.4, MACD: -25.4) suggest bearish momentum. An attractive entry zone lies between ₹1,300–₹1,400, closer to its recent low of ₹1,226. Investors should wait for correction before accumulating.
🕰️ Long-Term Holding Guidance: IKS offers strong fundamentals with excellent return ratios and low debt. However, stretched valuations limit near-term attractiveness. Long-term investors may consider holding only if accumulated at lower levels, with patience for earnings growth to justify valuations.
Positive
- Strong ROE (32.3%) and ROCE (35.0%)
- Low debt-to-equity ratio (0.07)
- Quarterly PAT growth of 50.2%
- Increase in FII (+0.54%) and DII (+1.17%) holdings
Limitation
- High P/E (62.3) compared to industry average (25.7)
- P/B ratio (~18.2) indicates premium valuation
- No dividend yield (0%)
- Weak technical momentum (RSI 37.4, MACD -25.4)
Company Negative News
- Stock trading below DMA 50 and DMA 200
- Valuation concerns with PEG ratio of 3.59
Company Positive News
- Strong quarterly profit growth
- Rising institutional investor confidence (FII & DII holdings up)
- High return ratios support long-term sustainability
Industry
- Industry P/E at 25.7, much lower than IKS valuation
- Sector supported by innovation and efficiency trends
- Moderate growth outlook with cyclical demand
Conclusion
IKS is financially strong with excellent return ratios and low debt, but valuations are stretched relative to industry benchmarks. Investors should wait for correction towards ₹1,300–₹1,400 before accumulating. Suitable for long-term holding only if entered at lower levels, with patience for earnings growth to align with valuation.
Would you like me to also prepare a peer comparison HTML snapshot of IKS versus other mid-cap technology-driven industrial peers to highlight relative valuation and growth positioning?